FDA-TRACK: Office of Clinical Policy and Programs
Office of Combination Products
Office of Combination Products (OCP) serves as a focal point for combination product (drug-device, biologic-device, drug-biologic, or drug-device-biologic products) issues for agency reviewers and industry.
Office of Orphan Products Development
Office of Orphan Products Development (OOPD) is dedicated to promoting the development of products (drugs, devices, biologics, and medical foods) that demonstrate promise for the diagnosis and/or treatment of rare diseases or conditions.
Office of Pediatric Therapeutics
Office of Pediatric Therapeutics (OPT) primary mission is to assure access for children to innovative, safe and effective medical products.